<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Rev Bras Cir Cardiovasc</journal-id><journal-title-group><journal-title>Revista Brasileira de Cirurgia Cardiovascular : &#x000f3;rg&#x000e3;o oficial da Sociedade Brasileira de Cirurgia Cardiovascular</journal-title></journal-title-group><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26313721</article-id><article-id pub-id-type="pmc">4541777</article-id><article-id pub-id-type="doi">10.5935/1678-9741.20150035</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Chronotropic incompetence in Chagas disease: effectiveness of blended
sensor (volume/minute and accelerometer)</article-title><trans-title-group xml:lang="pt"><trans-title>Compet&#x000ea;ncia cronotr&#x000f3;pica em chag&#x000e1;sicos:
efic&#x000e1;cia do duplo sensor (volume/minuto e
aceler&#x000f4;metro)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name><surname>Menezes Junior</surname><given-names>Antonio da Silva</given-names></name><degrees>MD, PhD</degrees><xref ref-type="aff" rid="aff01">1</xref><xref ref-type="corresp" rid="c01"/></contrib><contrib contrib-type="author"><name><surname>da Silva</surname><given-names>Aline Pereira</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff01">1</xref></contrib><contrib contrib-type="author"><name><surname>Profahl</surname><given-names>Giovana Gurian Batista</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff01">1</xref></contrib><contrib contrib-type="author"><name><surname>Ottobeli</surname><given-names>Catarine</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff01">1</xref></contrib><contrib contrib-type="author"><name><surname>Louzeiro</surname><given-names>Jutay Fernando Silva</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff01">1</xref></contrib><aff id="aff01"><label>1</label> Pontif&#x000ed;cia Universidade Cat&#x000f3;lica de Goi&#x000e1;s
(PUC-GO), Goi&#x000e2;nia, GO, Brazil.</aff></contrib-group><author-notes><corresp id="c01">Correspondence address: Antonio da Silva Menezes Junior, Hospital
Santa Helena e Pontif&#x000ed;cia Universidade Cat&#x000f3;lica de Goi&#x000e1;s, Rua
95, n&#x000ba; 99, Setor Sul &#x02013; Goi&#x000e2;nia, GO, Brazil - Zip code: 74083-100.
E-mail: <email>a.menezes.junior@uol.com.br</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>May-Jun</season><year>2015</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>May-Jun</season><year>2015</year></pub-date><volume>30</volume><issue>3</issue><fpage>311</fpage><lpage>315</lpage><history><date date-type="received"><day>21</day><month>11</month><year>2014</year></date><date date-type="accepted"><day>17</day><month>5</month><year>2015</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly
cited.</license-p></license></permissions><abstract><sec><title>Introduction</title><p>Technological progress of pacemakers has allowed the association of two or more
sensors in one heart rate system response. The accelerometer sensor measures the
intensity of the activity; it has a relatively rapid response to the beginning of
it, however, it may present insufficient response to less strenuous or of less
impact exercise. The minute ventilation sensor changes the pacing rate in response
to changes in respiratory frequency in relation to tidal volume, allowing
responses to situations of emotional stress and low impact exercises.</p></sec><sec><title>Objective</title><p>To evaluate the cardiorespiratory response of the accelerometer with respect to
the blended sensor (BS=accelerometer sensor+minute ventilation sensor) to exercise
in chagasic patients undergoing cardiopulmonary exercise test.</p></sec><sec><title>Methods</title><p>This was a prospective, observational, randomized, cross-sectional study. Patients
who met the inclusion criteria were selected. The maximum heart rate of the sensor
was programmed by age (220-age). The results were analyzed through t test with
paired samples (<italic>P</italic>&#x0003c;0.05).</p></sec><sec><title>Results</title><p>Sample was comprised of 44 patients, with a mean age of 66&#x000b1;10.4 years, 58%
were female, 54% as first implant, in 74% were functional class I and 26% were
functional class II, left ventricular ejection fraction was 58&#x000b1;7. As for
the cardiopulmonary test, maximum expected heart rate and VO2 were not achieved in
both the accelerometer sensor and the blended sensor, however, metabolic
equivalent in the blended sensor was higher than the expected, all data with
<italic>P</italic>&#x0003c;0.001.</p></sec><sec><title>Conclusion</title><p>Even though the maximal heart rate was not reached, the blended sensor provided a
physiological electrical sequence when compared to the accelerometer sensor,
providing better physical fitness test in cardiopulmonary hemodynamics and greater
efficiency.</p></sec></abstract><trans-abstract xml:lang="pt"><sec><title>Introdu&#x000e7;&#x000e3;o</title><p>O progresso tecnol&#x000f3;gico dos marca passos permitiu a
associa&#x000e7;&#x000e3;o de dois ou mais sensores em um &#x000fa;nico sistema de
resposta de frequ&#x000ea;ncia card&#x000ed;aca. O sensor aceler&#x000f4;metro afere
a intensidade da atividade, possui uma resposta relativamente r&#x000e1;pida ao
in&#x000ed;cio da mesma, por&#x000e9;m pode apresentar respostas insuficientes a
exerc&#x000ed;cios f&#x000ed;sicos menos intensos ou de menor impacto. O sensor
volume-minuto altera a taxa de estimula&#x000e7;&#x000e3;o card&#x000ed;aca em
resposta &#x000e0; varia&#x000e7;&#x000e3;o da frequ&#x000ea;ncia respirat&#x000f3;ria
quanto ao volume corrente, permitindo, assim, respostas a situa&#x000e7;&#x000f5;es
de estresse emocional e exerc&#x000ed;cios de baixo impacto.</p></sec><sec><title>Objetivo</title><p>Avaliar a resposta cardiorrespirat&#x000f3;ria do aceler&#x000f4;metro em
rela&#x000e7;&#x000e3;o ao duplo sensor ao exerc&#x000ed;cio em pacientes
chag&#x000e1;sicos submetidos ao teste ergoespirom&#x000e9;trico.</p></sec><sec><title>M&#x000e9;todos</title><p>Pesquisa prospectiva, observacional, randomizada e cruzada. Foram selecionados
pacientes que preenchiam os crit&#x000e9;rios de inclus&#x000e3;o. A
frequ&#x000ea;ncia card&#x000ed;aca m&#x000e1;xima do sensor foi programada por idade
(220-idade). Os resultados obtidos foram analisados pelo Teste T com amostras
pareadas (<italic>P</italic>&#x0003c;0,05).</p></sec><sec><title>Resultados</title><p>Amostra de 44 pacientes, com idade m&#x000e9;dia de 66&#x000b1;10,4, com 58% do sexo
feminino, 54% como primeiro implante, classe funcional I em 74% e II em 26%,
fra&#x000e7;&#x000e3;o de eje&#x000e7;&#x000e3;o do ventr&#x000ed;culo esquerdo de
58&#x000b1;7. Quanto ao ergoespirom&#x000e9;trico, a frequ&#x000ea;ncia
card&#x000ed;aca m&#x000e1;xima prevista e a VO2 m&#x000e1;xima prevista n&#x000e3;o
foram atingidas tanto no sensor aceler&#x000f4;metro quanto no sensor
volume-minuto, contudo, o equivalente metab&#x000f3;lico no sensor volume- minuto
foi superior &#x000e0; prevista, todos os dados com
<italic>P</italic>&#x0003c;0,001.</p></sec><sec><title>Conclus&#x000e3;o</title><p>Apesar da frequ&#x000ea;ncia card&#x000ed;aca m&#x000e1;xima n&#x000e3;o ter sido
atingida, o duplo sensor proporcionou uma sequ&#x000ea;ncia el&#x000e9;trica mais
fisiol&#x000f3;gica quando comparado ao sensor aceler&#x000f4;metro.</p></sec></trans-abstract><kwd-group><kwd>Chagas Cardiomyopathy</kwd><kwd>Cardiac Pacing, Artificial</kwd><kwd>Heart Rate</kwd><kwd>Prospective Studies</kwd></kwd-group></article-meta></front><body><table-wrap id="t01" orientation="portrait" position="float"><table frame="box" rules="groups"><thead><tr><th colspan="2" align="left" rowspan="1"><bold>Abbreviations, acronyms &#x00026;
symbols</bold></th></tr></thead><tbody><tr><td rowspan="1" colspan="1">APMHR</td><td rowspan="1" colspan="1">Age-predicted maximal heart rate</td></tr><tr><td rowspan="1" colspan="1">BS</td><td rowspan="1" colspan="1">Blended sensor</td></tr><tr><td rowspan="1" colspan="1">CI</td><td rowspan="1" colspan="1">Chronotropic incompetence</td></tr><tr><td rowspan="1" colspan="1">GAPC</td><td rowspan="1" colspan="1">Goi&#x000e1;s&#x02019; Arrhythmia and Pacemaker Center</td></tr><tr><td rowspan="1" colspan="1">HR</td><td rowspan="1" colspan="1">Heart rate</td></tr><tr><td rowspan="1" colspan="1">MCA</td><td rowspan="1" colspan="1">Accelerometer</td></tr><tr><td rowspan="1" colspan="1">MET</td><td rowspan="1" colspan="1">Metabolic equivalent</td></tr><tr><td rowspan="1" colspan="1">MVS</td><td rowspan="1" colspan="1">Minute ventilation sensor</td></tr><tr><td rowspan="1" colspan="1">PUC</td><td rowspan="1" colspan="1">Pontificai Catholic University</td></tr><tr><td rowspan="1" colspan="1">REC</td><td rowspan="1" colspan="1">Research Ethics Committee</td></tr><tr><td rowspan="1" colspan="1">TV</td><td rowspan="1" colspan="1">Tidal volume</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Recent estimates from the World Health Organization indicate that 18 million people are
infected by the <italic>Trypanosoma cruzi</italic>. In addition, two hundred thousand
new cases happen every year. After the acute phase of the Chagas Disease, the infected
individuals go through its undetermined stage, which has low morbimortality rates. Half
of those will remain stable for the rest of their lives. The other half will develop a
chronic form of the illness, followed by cardiac and/or digestive involvement. The
chagasic cardiopathy is the most frequent chronic form of the Chagas Disease and it
results in, at least, 21,000 deaths around the world every year<sup>[<xref rid="r01" ref-type="bibr">1</xref>]</sup>.</p><p>Morphological studies have shown that Chagas patients have parasympathetic denervation
due to three mechanisms: <italic>T. cruzi</italic> direct parasitism, degeneration
caused by periganglionar inflammation, and autoimmune reaction against the neurons.
Besides, these patients have abnormal autonomic cardiac regulation (dysautonomia).
Available studies show that it happens because of a lower sensitivity in the sinus node
to the sympathetic stimulation and circulating catecholamines as well as some damage to
the vagal mediated mechanism, which responds to transitory pressure
changes<sup>[<xref rid="r02" ref-type="bibr">2</xref>]</sup>.</p><sec><title>Chronotropic Incompetence</title><p>Low tolerance to exercising in patients who have Chagas' disease may be attributed,
among other causes, to chronotropic incompetence (CI), defined as the heart's
inability to elevate the HR to proportionally fulfil the raise in metabolic
demand<sup>[<xref rid="r03" ref-type="bibr">3</xref>,<xref rid="r04" ref-type="bibr">4</xref>]</sup>.</p><p>An inappropriate chronotropic response to exercising in Chagas Disease patients
lowers the maximal O<sub>2</sub> consumption (VO<sub>2</sub> max) to between 15% and
20%. It reduces the capacity to exercise. The lack of standardization in the CI
diagnostic criteria contributes to the large range of estimated prevalence in medical
literature (9% to 89%). CI has been commonly diagnosed when there is failure in
reaching an arbitrary percentage (85%, 80% and, less frequently, 70%) of the
age-predicted maximal heart rate (APMHR), usually estimated by Astrand's formula
(APMHR=220 - age&#x000b1;10) in the exercise stress test<sup>[<xref rid="r03" ref-type="bibr">3</xref>]</sup>.</p><p>Another variable used in the CI diagnosis is the HR reserve, which is defined as the
difference between resting HR and maximal HR during graded exercise stress. When
determined in percentages (adjusted HR reserve), most studies consider values lower
than 80% of age-predicted heart rate reserve (APHRR)<sup>[<xref rid="r05" ref-type="bibr">5</xref>]</sup>. Therefore, four different
types of CI with similar clinical repercussion are recognized: (a) failure to reach
maximal HR, (b) delay in reaching maximal HR, (c) post-exercise HR inadequate
recovery and (d) HR instability during exercise.</p></sec><sec><title>Sensing equipment</title><p>Sensing equipment was introduced in the cardiac stimulation area as an attempt to
mimic the sinus node physiological response by promoting heart rate elevation due to
the raise in metabolic demand during physical exercise and emotional stress. When
compared to fixed heart rate, its benefits are a result of the improvement in
hemodynamic status, which is acchieved through the restoration of the cardiac debt to
levels that are closer ideal, and a reduction in the arteriovenous oxygen difference.
It results in performance and standard of living improvement.</p><p>In clinical practice, the most used sensing equipment are the accelerometer (ACCEL),
which monitors variations in the individual's acceleration through piezoresistive or
piezoelectric material, and the minute volume (MVS), which detects the thoracic
impedance resulting from the raise in respiratory rate and tidal volume (TV).</p><p>The accelerometer sensor (ACCEL) measures the intensity of the activities. Moreover,
it responds relatively fast in the beginning of the movements, yet it might present
different insufficient responses to less intense or low impact physical exercises.
The minute volume sensor (MVS) changes the cardiac stimulation ratio in response to
the variation of the respiratory rate concerning the tidal volume. Hence, it allows
responses to emotional stress situations and low impact exercises.</p><p>The recently obtained technological advance regarding the development of the sensing
equipment<sup>[<xref rid="r04" ref-type="bibr">4</xref>]</sup>,
especially the double sensors, and the poor literature on how to use them,
particularly in Chagas Disease patients must be taken into account. Therefore, our
study aims at evaluating the cardiorespiratory response of the accelerometer towards
the double sensor (ACCEL + MVS) as far as exercising in chagasic patients who
underwent the ergoespirometry test is concerned.</p></sec></sec><sec sec-type="methods"><title>METHODS</title><p>This is a forward-looking, observational, randomized and cross-sectional study, which
evaluated 44 patients. They were selected according to the following criteria: presence
Chagas Disease, age between 18 and 70 years old, living in Goi&#x000e2;nia's metropolitan
zone, having the sinus node disease associated to chronotropic incompetence, and using
an artificial dual chamber pacemaker with two sensors, accelerometer and minute
volume.</p><p>VO<sub>2</sub> max represents the maximal oxygen consumption as also being the maximal
amount of energy that may be produced by the aerobic metabolism in a given time unit.
The energy cost in patients in the exercise stress test is given in METS, defined as
metabolic equivalent, or the enough amount of energy for an individual to keep resting.
When the cost is expressed in METS, we know how many times the resting metabolism was
multiplied during an activity<sup>[<xref rid="r06" ref-type="bibr">6</xref>]</sup>.</p><p>Patients signed a n informed consent, and the project was approved by the Research
Ethics Committee (REC) from PUC (Pontifical Catholic University)/Goi&#x000e1;s,
registered under the number 210.294/2013. Patients also underwent anamnesis, besides
physical and ergoespirometry tests. The latter happened according to the Bruce protocol,
on a treadmill. First, the patients remained in the biosensor ACCEL programming for
6.2&#x000b1;2 months and in DS for 7.1&#x000b1;2.5 months (r&#x0003e;0.05).</p><p>The biosensors programming corresponded to Astrand's formula (220 - age). Thus, they
were individually programmed (named predicted rate). The patients were encouraged to
exercise up to their maximal age or predicted HR (sensor-programmed).</p><p>The participants were chosen at random among those who used only one sensor or a double
one and, then, they were cross-checked. Quantitative variables were described by the
average and measure of dispersion (standard deviation). The obtained results were
analyzed in the T Test with paired samples (r&#x0003c;0.05) and IBM SPSS 21 program.</p></sec><sec sec-type="results"><title>RESULTS</title><p>The 44 patients data were kept in their electronic health records, protected with a
password in the Goi&#x000e1;s Arrhythmia and Pacemaker Center (GAPC). Gender and age were
analyzed as epidemiological characteristics. There was predominance of the female gender
(58%) and the average age was 66&#x000b1;10.4 years old. Among these patients, 54%
underwent the first implant, and 74% had heart failure class I and 26% had class II. The
average ejection fraction from the LV through Simpson's method was 58&#x000b1;7%.</p><p>In the ergoespirometry test, the maximal predicted HR average obtained by patients was
153.0&#x000b1;9,4 bpm. In the patients whose pacemakers were programmed with the
accelerometer, this rate reached 106.3&#x000b1;2.7 bpm, while the ones with double sensor
had a 132.5&#x000b1;6.3 bpm value (r&#x0003c;0.0001, shown in <xref ref-type="fig" rid="f01">Figure 1</xref>). As for oxygen consumption, the predicted value of VO<sub>2</sub>
max was 48.2&#x000b1;1.7. The accelerometer reached 34.9&#x000b1;9.7 and the double sensor
reached 23.6&#x000b1;7.1 (r&#x0003c;0.0001). Eventually, the predicted metabolic equivalent
(MET) reached a 6.8&#x000b1;1.6 value, with 5.8&#x000b1;1.7 METs in the accelerometer and
7.8&#x000b1;2.3 METs in the double sensor (r&#x0003c;0.0001) (<xref ref-type="fig" rid="f02">Figures 2</xref>, <xref ref-type="fig" rid="f03">3</xref> and <xref ref-type="fig" rid="f04">4</xref>).</p><fig id="f01" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Averages obtained in the erogoespirometry test.</p><p>ACCEL=Accelerometer; MET=Metabolic equivalent; DS=Double Sensor</p></caption><graphic xlink:href="rbccv-30-03-0311-g01"/></fig><fig id="f02" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Maximal Heart Rate and standard deviation (in bpm) obtained in the ergoespirometry
test.</p></caption><graphic xlink:href="rbccv-30-03-0311-g02"/></fig><fig id="f03" orientation="portrait" position="float"><label>Fig. 3</label><caption><p>VO<sub>2</sub> max: value in the ergoespirometry test in the different groups
(average and standard deviation).</p></caption><graphic xlink:href="rbccv-30-03-0311-g03"/></fig><fig id="f04" orientation="portrait" position="float"><label>Fig. 4</label><caption><p>Average and standard deviation of metabolic equivalent in the different
groups.</p></caption><graphic xlink:href="rbccv-30-03-0311-g04"/></fig><sec><title>Arrhythmia Density Analysis</title><p>a) Atrial: there was no statistically relevant difference between the two groups
(r&#x0003e;0.05)</p><p>b) Ventricular: there was no statistically relevant difference between the two groups
(r&#x0003e;0.05)</p></sec></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>In cardiac conduction system diseases, the chronotropic pathway gets interrupted.
Therefore, for the maintenance of normal physiology, there has to be installation of an
artificial stimulation system, enough to supply the heart with electric disability. The
great pacemakers evolution is due to their circuits and to how they adapt themselves to
the metabolic needs of the patients<sup>[<xref rid="r06" ref-type="bibr">6</xref>]</sup>, even with so many types of available devices and sensors.
The minute volume sensor receives the respiratory rate and it is well related to
physical exercise. However, it is not completely reliable in patients with obstructive
pulmonary disease and in cases of hyperventilation. The accelerometer sensor measures
the body's activity or movement associated with physical activity. It is the most used
sensor due to its low cost and easy programming. Nevertheless, it might not respond well
in very intense exercises that involve less body movements or in emotional stress
moments at rest<sup>[<xref rid="r07" ref-type="bibr">7</xref>-<xref rid="r09" ref-type="bibr">9</xref>]</sup>.</p><p>These data support our results. In fact, the statistically relevant difference in the
metabolic equivalent (MET), comparing the ACCEL activity to the DS (ACCEL + MVS), works
in a complementary way and shows great advantages and improvements in the chronotropic
response. The high cost, need for closer following and reduction in the pacemaker
operating life may be considered as disadvantages<sup>[<xref rid="r07" ref-type="bibr">7</xref>,<xref rid="r09" ref-type="bibr">9</xref>]</sup>.</p><p>In our results, none of the groups reached maximal predicted HR. That is why we cannot
ascertain whether the chronotropic insufficiency is the one that leads to a lower
aerobic capacity or vice-versa. In the Rocha et al.<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup> study, similar results were found, as far as HR
is concerned. It is important to note that, after the adjustment for maximal estimated
oxygen consumption, the chagasic patients went on having less aerobic capacity. It
proves that the lower aerobic capacity is not the main cause of the chronotropic
insufficiency observed amongst the Chagas Disease patients.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>Even though the heart rate was not reached, the double sensor provided a more
physiological electric sequence compared to the accelerometer sensor.</p><table-wrap id="t02" orientation="portrait" position="float"><table frame="box" rules="groups"><thead><tr><th colspan="2" align="left" rowspan="1"><bold>Authors&#x02019; roles &#x00026;
responsibilities</bold></th></tr></thead><tbody><tr><td rowspan="1" colspan="1">ASMJ</td><td rowspan="1" colspan="1">Researcher</td></tr><tr><td rowspan="1" colspan="1">APS</td><td rowspan="1" colspan="1">Analysis and/or interpretation of data; statistical analysis;
implementation of projects and/or experiments</td></tr><tr><td rowspan="1" colspan="1">GGBP</td><td rowspan="1" colspan="1">Performing operations and/or experiments; manuscript writing or critical
review of its content</td></tr><tr><td rowspan="1" colspan="1">CO</td><td rowspan="1" colspan="1">Analysis and/or interpretation of data; statistical analysis; study
design</td></tr><tr><td rowspan="1" colspan="1">JFSL</td><td rowspan="1" colspan="1">Conception and design; implementation of projects and/or experiments</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="supported-by"><p>No financial support.</p></fn><fn fn-type="other"><p>This study was carried out at Hospital Santa Helena e Pontif&#x000ed;cia Universidade
Cat&#x000f3;lica de Goi&#x000e1;s (PUC-GO), Goi&#x000e2;nia, GO, Brazil.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r01"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rassi</surname><given-names>A</given-names><suffix>Jr</suffix></name><name><surname>Rassi</surname><given-names>A</given-names></name><name><surname>Rassi</surname><given-names>SG</given-names></name></person-group><article-title>Predictors of mortality in chronic Chagas disease: a systematic review
of observational studies</article-title><source>Circulation</source><year>2007</year><volume>115</volume><issue>9</issue><fpage>1101</fpage><lpage>1108</lpage><pub-id pub-id-type="pmid">17339568</pub-id></element-citation></ref><ref id="r02"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marin-Neto</surname><given-names>JA</given-names></name><name><surname>Cunha-Neto</surname><given-names>E</given-names></name><name><surname>Maciel</surname><given-names>BC</given-names></name><name><surname>Sim&#x000f5;es</surname><given-names>MV</given-names></name></person-group><article-title>Pathogenesis of chronic Chagas heart disease</article-title><source>Circulation</source><year>2007</year><volume>115</volume><issue>9</issue><fpage>1109</fpage><lpage>1123</lpage><pub-id pub-id-type="pmid">17339569</pub-id></element-citation></ref><ref id="r03"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menezes</surname><given-names>AS</given-names><suffix>Junior</suffix></name><name><surname>Comerlatto</surname><given-names>GC</given-names></name><name><surname>Lopes</surname><given-names>LHM</given-names></name></person-group><article-title>O uso da frequ&#x000ea;ncia adaptativa na terapia de
ressincroniza&#x000e7;&#x000e3;o card&#x000ed;aca: revis&#x000e3;o
liter&#x000e1;ria</article-title><source>Relampa</source><year>2012</year><volume>25</volume><issue>2</issue><fpage>134</fpage><lpage>145</lpage></element-citation></ref><ref id="r04"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arce</surname><given-names>M</given-names></name><name><surname>VAN Grieken</surname><given-names>J</given-names></name><name><surname>Femen&#x000ed;a</surname><given-names>F</given-names></name><name><surname>Arrieta</surname><given-names>M</given-names></name><name><surname>McIntyre</surname><given-names>WF</given-names></name><name><surname>Baranchuk</surname><given-names>A</given-names></name></person-group><article-title>Permanent pacing in patients with Chagas' disease</article-title><source>Pacing Clin Electrophysiol</source><year>2012</year><volume>35</volume><issue>12</issue><fpage>1494</fpage><lpage>1497</lpage><pub-id pub-id-type="pmid">23078655</pub-id></element-citation></ref><ref id="r05"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okin</surname><given-names>PM</given-names></name><name><surname>Lauer</surname><given-names>MS</given-names></name><name><surname>Kligfield</surname><given-names>P</given-names></name></person-group><article-title>Chronotropic response to exercise. Improved performance of ST-segment
depression criteria after adjustment for heart rate reserve</article-title><source>Circulation</source><year>1996</year><volume>94</volume><issue>12</issue><fpage>3226</fpage><lpage>3231</lpage><pub-id pub-id-type="pmid">8989133</pub-id></element-citation></ref><ref id="r06"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coelho-Ravagnani</surname><given-names>CF</given-names></name><name><surname>Melo</surname><given-names>FCL</given-names></name><name><surname>Ravagnani</surname><given-names>FCP</given-names></name><name><surname>Burini</surname><given-names>FHP</given-names></name><name><surname>Burini</surname><given-names>RC</given-names></name></person-group><article-title>Estimation of metabolic equivalent (MET) of an exercise protocol based
on indirect calorimetry</article-title><source>Rev Bras Med Esporte</source><year>2013</year><volume>19</volume><issue>2</issue><fpage>134</fpage><lpage>138</lpage></element-citation></ref><ref id="r07"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilliam 3rd</surname><given-names>FR</given-names></name><name><surname>Giudici</surname><given-names>M</given-names></name><name><surname>Benn</surname><given-names>A</given-names></name><name><surname>Koplan</surname><given-names>B</given-names></name><name><surname>Berg</surname><given-names>KJ</given-names></name><name><surname>Kraus</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Design and rationale of the assessment of proper physiologic response
with rate adaptive pacing driven by minute ventilation or accelerometer
(APPROPRIATE) trial</article-title><source>J Cardiovasc Transl Res</source><year>2011</year><volume>4</volume><issue>1</issue><fpage>21</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">21104046</pub-id></element-citation></ref><ref id="r08"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Occhetta</surname><given-names>E</given-names></name><name><surname>Bortnik</surname><given-names>M</given-names></name><name><surname>Marino</surname><given-names>P</given-names></name></person-group><article-title>Usefulness of hemodynamic sensors for physiologic cardiac pacing in
heart failure patients</article-title><source>Cardiol Res Pract</source><year>2011</year><volume>2011</volume><fpage>925653</fpage><lpage>925653</lpage><pub-id pub-id-type="pmid">21461359</pub-id></element-citation></ref><ref id="r09"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pilat</surname><given-names>E</given-names></name><name><surname>Mlynarski</surname><given-names>R</given-names></name><name><surname>Wlodyka</surname><given-names>A</given-names></name><name><surname>Kargul</surname><given-names>W</given-names></name></person-group><article-title>Influence of DDD rate response pacing with integrated double sensors
on physical efficiency and quality of life</article-title><source>Europace</source><year>2008</year><volume>10</volume><issue>10</issue><fpage>1189</fpage><lpage>1194</lpage><pub-id pub-id-type="pmid">18713758</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rocha</surname><given-names>ALL</given-names></name><name><surname>Rocha</surname><given-names>MOC</given-names></name><name><surname>Teixeira</surname><given-names>BOS</given-names></name><name><surname>Lombardi</surname><given-names>F</given-names></name><name><surname>Abreu</surname><given-names>CDG</given-names></name><name><surname>Bittencourt</surname><given-names>RJ</given-names></name><etal/></person-group><article-title>&#x000cd;ndice cronotr&#x000f3;pico-metab&#x000f3;lico na doen&#x000e7;a
de Chagas</article-title><source>Rev Soc Bras Med Trop</source><year>2005</year><volume>38</volume><issue>5</issue><fpage>373</fpage><lpage>376</lpage><pub-id pub-id-type="pmid">16172749</pub-id></element-citation></ref></ref-list></back></article>